Celsion announces commercialization of reagent products
Celsion’s reagent products are based on its newly acquired proprietary delivery platform technologies, TheraPlas and TheraSilence. TheraPlas and TheraSilence are designed for optimal transfection (intra-cellular delivery) of plasmid
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.